Neil Dahiya

Medtronic and Kuros Biosciences Sign Exclusive Sales Partnership for Spinal Technologies

Kuros Biosciences USA has recently revealed a significant five-year exclusive sales agency collaboration with Medtronic, aimed at promoting the use of its MagnetOs bone graft technology. Kuros Biosciences USA — a fully owned subsidiary of Kuros Biosciences AG (headquartered in […]

Medtronic and Kuros Biosciences Sign Exclusive Sales Partnership for Spinal Technologies Read More »

Fire1 Secures $120 Million for Innovative Heart Failure Tech with Medtronic’s Backing

Fire1 announced today the successful completion of a $120 million funding round aimed at accelerating the development of its heart failure management technology. A significant milestone was reached as the company received breakthrough device designation from the FDA. Additionally, its

Fire1 Secures $120 Million for Innovative Heart Failure Tech with Medtronic’s Backing Read More »